chr19-38499974-C-T

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000540.3(RYR1):​c.7281C>T​(p.Ala2427Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00532 in 1,614,144 control chromosomes in the GnomAD database, including 230 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0083 ( 32 hom., cov: 31)
Exomes 𝑓: 0.0050 ( 198 hom. )

Consequence

RYR1
NM_000540.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:15

Conservation

PhyloP100: -3.77
Variant links:
Genes affected
RYR1 (HGNC:10483): (ryanodine receptor 1) This gene encodes a ryanodine receptor found in skeletal muscle. The encoded protein functions as a calcium release channel in the sarcoplasmic reticulum but also serves to connect the sarcoplasmic reticulum and transverse tubule. Mutations in this gene are associated with malignant hyperthermia susceptibility, central core disease, and minicore myopathy with external ophthalmoplegia. Alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.68).
BP6
Variant 19-38499974-C-T is Benign according to our data. Variant chr19-38499974-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 159857.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-38499974-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-3.77 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0618 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RYR1NM_000540.3 linkc.7281C>T p.Ala2427Ala synonymous_variant Exon 45 of 106 ENST00000359596.8 NP_000531.2 P21817-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RYR1ENST00000359596.8 linkc.7281C>T p.Ala2427Ala synonymous_variant Exon 45 of 106 5 NM_000540.3 ENSP00000352608.2 P21817-1
RYR1ENST00000355481.8 linkc.7281C>T p.Ala2427Ala synonymous_variant Exon 45 of 105 1 ENSP00000347667.3 P21817-2
RYR1ENST00000594335.5 linkn.732C>T non_coding_transcript_exon_variant Exon 6 of 49 1 ENSP00000470927.2 M0R014
RYR1ENST00000599547.6 linkn.7281C>T non_coding_transcript_exon_variant Exon 45 of 80 2 ENSP00000471601.2 M0R127

Frequencies

GnomAD3 genomes
AF:
0.00835
AC:
1270
AN:
152166
Hom.:
32
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00429
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0374
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.0677
Gnomad SAS
AF:
0.0257
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000265
Gnomad OTH
AF:
0.0110
GnomAD3 exomes
AF:
0.0136
AC:
3414
AN:
251370
Hom.:
93
AF XY:
0.0121
AC XY:
1648
AN XY:
135882
show subpopulations
Gnomad AFR exome
AF:
0.00375
Gnomad AMR exome
AF:
0.0440
Gnomad ASJ exome
AF:
0.00198
Gnomad EAS exome
AF:
0.0596
Gnomad SAS exome
AF:
0.0202
Gnomad FIN exome
AF:
0.000277
Gnomad NFE exome
AF:
0.000325
Gnomad OTH exome
AF:
0.00880
GnomAD4 exome
AF:
0.00501
AC:
7319
AN:
1461860
Hom.:
198
Cov.:
36
AF XY:
0.00527
AC XY:
3829
AN XY:
727232
show subpopulations
Gnomad4 AFR exome
AF:
0.00388
Gnomad4 AMR exome
AF:
0.0411
Gnomad4 ASJ exome
AF:
0.00184
Gnomad4 EAS exome
AF:
0.0728
Gnomad4 SAS exome
AF:
0.0201
Gnomad4 FIN exome
AF:
0.000356
Gnomad4 NFE exome
AF:
0.000177
Gnomad4 OTH exome
AF:
0.00748
GnomAD4 genome
AF:
0.00834
AC:
1270
AN:
152284
Hom.:
32
Cov.:
31
AF XY:
0.00984
AC XY:
733
AN XY:
74456
show subpopulations
Gnomad4 AFR
AF:
0.00428
Gnomad4 AMR
AF:
0.0372
Gnomad4 ASJ
AF:
0.00115
Gnomad4 EAS
AF:
0.0676
Gnomad4 SAS
AF:
0.0253
Gnomad4 FIN
AF:
0.0000941
Gnomad4 NFE
AF:
0.000265
Gnomad4 OTH
AF:
0.0137
Alfa
AF:
0.00181
Hom.:
1
Bravo
AF:
0.0109
Asia WGS
AF:
0.0530
AC:
185
AN:
3478
EpiCase
AF:
0.000109
EpiControl
AF:
0.000356

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:15
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Apr 22, 2014
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Jan 11, 2024
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Dec 19, 2016
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jun 07, 2016
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:3
Oct 17, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Malignant hyperthermia, susceptibility to, 1 Benign:2
Sep 16, 2022
Color Diagnostics, LLC DBA Color Health
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Congenital multicore myopathy with external ophthalmoplegia Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

RYR1-related disorder Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Neuromuscular disease, congenital, with uniform type 1 fiber Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Central core myopathy Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.68
CADD
Benign
1.7
DANN
Benign
0.57

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs77310009; hg19: chr19-38990614; COSMIC: COSV62088367; API